139 related articles for article (PubMed ID: 9032353)
1. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
[TBL] [Abstract][Full Text] [Related]
2. Cross-Reactivity of HBe Antigen-Specific Polyclonal Antibody with HBc Antigen.
Hojatizadeh M; Amiri MM; Mobini M; Hassanzadeh Makoui M; Ghaedi M; Ghotloo S; Peyghami K; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
Viral Immunol; 2023; 36(6):378-388. PubMed ID: 37294935
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B.
Kondo Y; Kobayashi K; Ueno Y; Shiina M; Niitsuma H; Kanno N; Kobayashi T; Shimosegawa T
World J Gastroenterol; 2006 Jul; 12(27):4310-7. PubMed ID: 16865771
[TBL] [Abstract][Full Text] [Related]
4. Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein.
DiMattia MA; Watts NR; Stahl SJ; Grimes JM; Steven AC; Stuart DI; Wingfield PT
Structure; 2013 Jan; 21(1):133-142. PubMed ID: 23219881
[TBL] [Abstract][Full Text] [Related]
5. IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B.
Chua C; Salimzadeh L; Ma AT; Adeyi OA; Seo H; Boukhaled GM; Mehrotra A; Patel A; Ferrando-Martinez S; Robbins SH; La D; Wong D; Janssen HLA; Brooks DG; Feld JJ; Gehring AJ
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055623
[TBL] [Abstract][Full Text] [Related]
6. Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice.
Amemiya K; Bush GV; DeShazer D; Waag DM
Infect Immun; 2002 May; 70(5):2319-25. PubMed ID: 11953366
[TBL] [Abstract][Full Text] [Related]
7. Early application of IFNγ mediated the persistence of HBV in an HBV mouse model.
Song J; Sun X; Zhou Y; Li S; Wu J; Yang L; Zhou D; Yang Y; Liu A; Lu M; Michael R; Qin L; Yang D
Antiviral Res; 2024 May; 225():105872. PubMed ID: 38556058
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccination favours memory rather than effector B cell responses.
Laylor R; Porakishvili N; De Souza JB; Playfair JH; Delves PJ; Lund T
Clin Exp Immunol; 1999 Jul; 117(1):106-12. PubMed ID: 10403923
[TBL] [Abstract][Full Text] [Related]
9. Parenteral-Oral Immunization with Plant-Derived HBcAg as a Potential Therapeutic Vaccine against Chronic Hepatitis B.
Pyrski M; Mieloch AA; Plewiński A; Basińska-Barczak A; Gryciuk A; Bociąg P; Murias M; Rybka JD; Pniewski T
Vaccines (Basel); 2019 Dec; 7(4):. PubMed ID: 31835350
[TBL] [Abstract][Full Text] [Related]
10. Efficient induction of T helper type 1-mediated immune responses in antigen-primed mice by anti-CD3 single-chain Fv/interleukin-18 fusion DNA.
Kim EJ; Cho D; Kim TS
Immunology; 2004 Jan; 111(1):27-34. PubMed ID: 14678196
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar localization of human hepatitis B virus capsid protein.
Ning B; Shih C
J Virol; 2004 Dec; 78(24):13653-68. PubMed ID: 15564475
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component.
Kopf M; Herren S; Wiles MV; Pepys MB; Kosco-Vilbois MH
J Exp Med; 1998 Nov; 188(10):1895-906. PubMed ID: 9815267
[TBL] [Abstract][Full Text] [Related]
13. T-bet regulates IgG class switching and pathogenic autoantibody production.
Peng SL; Szabo SJ; Glimcher LH
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5545-50. PubMed ID: 11960012
[TBL] [Abstract][Full Text] [Related]
14. A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.
Sominskaya I; Skrastina D; Petrovskis I; Dishlers A; Berza I; Mihailova M; Jansons J; Akopjana I; Stahovska I; Dreilina D; Ose V; Pumpens P
PLoS One; 2013; 8(9):e75938. PubMed ID: 24086668
[TBL] [Abstract][Full Text] [Related]
15. Role of the propeptide in controlling conformation and assembly state of hepatitis B virus e-antigen.
Watts NR; Conway JF; Cheng N; Stahl SJ; Steven AC; Wingfield PT
J Mol Biol; 2011 Jun; 409(2):202-13. PubMed ID: 21463641
[TBL] [Abstract][Full Text] [Related]
16. Absolute Quantification of Hepatitis B Core Antigen (HBcAg) Virus-like Particles and Bound Nucleic Acids.
Valentic A; Böhner N; Hubbuch J
Viruses; 2023 Dec; 16(1):. PubMed ID: 38275948
[TBL] [Abstract][Full Text] [Related]
17. Construction of chimeric immunogens: Bioactive fragment of human IL-1β or polytuftsin (PT) capable of eliciting immune responses to HIV peptides.
Gokulan K; Khare S; Rao DN
Indian J Clin Biochem; 1998 Jul; 13(2):111-8. PubMed ID: 23105191
[TBL] [Abstract][Full Text] [Related]
18. Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer.
Hamilton DH; Bretscher PA
Cancer Immunol Immunother; 2008 Aug; 57(8):1125-36. PubMed ID: 18188562
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus e antigen induces atypical metabolism and differentially regulates programmed cell deaths of macrophages.
Li Y; Wu C; Lee J; Ning Q; Lim J; Eoh H; Wang S; Hurrell BP; Akbari O; Ou JJ
PLoS Pathog; 2024 Mar; 20(3):e1012079. PubMed ID: 38466743
[TBL] [Abstract][Full Text] [Related]
20. Promoter-regulated
Chen C; Zhou J; Men D; Zhang XE
Nanoscale; 2022 Nov; 14(43):16180-16184. PubMed ID: 36278831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
